Previous literature identified that it has been proposed that CHMP2A, a subunit of endosomal sorting complexes required for transport III (ESCRT-III), may help enhance the effect of NK cells on tumor cells (Bernareggi et al., 2022). This evidence concerns the gene CHMP2A and neoplasm.